DocSym
β
Searchsearch
Search
(Y57.2) Antidotes and chelating agents, not elsewhere classified
More details coming soon
589 106 in individuals diagnosis antidotes and chelating agents, not elsewhere classified confirmed
5 914 deaths with diagnosis antidotes and chelating agents, not elsewhere classified
1% mortality rate associated with the disease antidotes and chelating agents, not elsewhere classified
Diagnosis antidotes and chelating agents, not elsewhere classified is diagnosed Women are 16.60% more likely than Men
245 650
Men receive the diagnosis antidotes and chelating agents, not elsewhere classified
4 034 (1.6 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
343 456
Women receive the diagnosis antidotes and chelating agents, not elsewhere classified
1 880 (0.5 %)Died from this diagnosis.
Risk Group for the Disease antidotes and chelating agents, not elsewhere classified - Men aged 65-69 and Women aged 70-74
In Men diagnosis is most often set at age 0-95+
in in men, the disease manifests at any agein in women, the disease manifests at any age
In Women diagnosis is most often set at age 0-95+
Disease Features antidotes and chelating agents, not elsewhere classified
Absence or low individual and public risk
Antidotes and chelating agents, not elsewhere classified - what does this mean
Antidotes and chelating agents, not elsewhere classified, are chemical compounds that are used to counteract the effects of toxins or other hazardous substances in the body. these agents work by binding to the toxins, preventing them from further interacting with body tissues and organs, and allowing the body to safely excrete them.
What happens during the disease - antidotes and chelating agents, not elsewhere classified
Antidotes and chelating agents, not elsewhere classified, are used to treat toxicities caused by heavy metals, pesticides, and other chemicals. these agents bind to the toxic substances and render them less harmful or inert, preventing further damage to the body. in some cases, the agents may also help the body to eliminate the toxins from the system.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Blood tests
- Urine tests
- Tissue biopsies
- Imaging tests (e.g. X-ray, MRI)
- Genetic tests
- Antidote administration
- Chelating agent administration
- Toxicology tests
Treatment and Medical Assistance
Main goal of the treatment: To reduce the toxicity of the antidotes and chelating agents.
- Administering antidotes and chelating agents
- Monitoring the patient's response to treatment
- Monitoring the levels of toxins in the patient's body
- Adjusting the dosage of antidotes and chelating agents as needed
- Providing supportive care, such as oxygen therapy and nutrition
- Providing psychological support to the patient and their family
- Educating the patient and their family about the disease and its treatment
- Monitoring for any side effects of the treatment
- Referring the patient to a specialist if needed
10 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Antidotes and chelating agents, not elsewhere classified - Prevention
Prevention of antidotes and chelating agents, not elsewhere classified, involves avoiding exposure to toxins and hazardous substances, wearing protective clothing when handling such substances, and following safety protocols when working with them. additionally, regular health check-ups can help detect any early signs of poisoning and allow for prompt treatment.